Liu et al. concluded that KLHL17 upregulation in NSCLC promotes tumor cell proliferation and migration via an increase in RhoA expression, as well as activation of the pathway responsible for Ras/MAPK signaling [68]. The gene discussed is RHOA; the disease is neoplasm.